Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-24 @ 2:47 PM
Ignite Modification Date:
2025-12-25 @ 1:15 PM
NCT ID:
NCT02513459
Group ID:
EG001
Title:
Risankizumab 180 mg SC
Description:
Maintenance treatment every 8 weeks (q8w) from Visit 2 through the end of trial (EOT) visit. Participants who re-gained their clinical response following the re-induction treatment could continue with maintenance treatment beginning at Visit 5.
Deaths Number Affected:
0
Deaths Number At Risk:
None
Serious Number Affected:
23
Serious Number At Risk:
65
Other Number Affected:
52
Other Number At Risk:
65
Study:
NCT02513459
Results Section:
NCT02513459
Adverse Events Module:
NCT02513459